In April 2025, the US Food and Drug Administration (FDA) published a roadmap for leveraging new approach methodologies (NAMs), including in silico approaches such as artificial intelligence (AI), to ...

Who needs rewrites? This metadata-powered architecture fuses AI and ETL so smoothly, it turns pipelines into self-evolving ...